Interrogation of Antigen Display on Individual Vaccine Nanoparticles for Achieving Neutralizing Antibody Responses against Hepatitis C Virus-Reference-Cited by-同舟云学术

Interrogation of Antigen Display on Individual Vaccine Nanoparticles for Achieving Neutralizing Antibody Responses against Hepatitis C Virus

Published:2018-11-21 Issue:12 Volume:18 Page:7832-7838
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Bazzill Joseph D.¹²,Ochyl Lukasz J.¹²,Giang Erick³,Castillo Shaun³,Law Mansun³,Moon James J.¹²⁴^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109, United States

2. Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan 48109, United States

3. Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California 92037, United States

4. Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States

Funder

National Heart, Lung, and Blood Institute

National Institute of Allergy and Infectious Diseases

National Institute of Biomedical Imaging and Bioengineering

Alberta Emerald Foundation

U.S. Department of Defense

Division of Chemical, Bioengineering, Environmental, and Transport Systems

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.8b03601

Reference20 articles.

1. Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus

2. Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis

3. Guidelines for the Screening, Care and Treatment of Persons with Chronic Hpeatits C Infection; World Health Organization: Geneva, Switzerland, 2016.

4. Hepatitis C in Injection-Drug Users — A Hidden Danger of the Opioid Epidemic

5. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate;Nature Communications;2022-11-25

2. Emerging vaccine nanotechnology: From defense against infection to sniping cancer;Acta Pharmaceutica Sinica B;2022-05

3. DNA‐Directed Patterning for Versatile Validation and Characterization of a Lipid‐Based Nanoparticle Model of SARS‐CoV‐2;Advanced Science;2021-10-21

4. 3D printing technologies for in vitro vaccine testing platforms and vaccine delivery systems against infectious diseases;Essays in Biochemistry;2021-08

5. Immunopotentiating and Delivery Systems for HCV Vaccines;Viruses;2021-05-25